Dyne Therapeutics Shares Fall 31% Premarket With No Catalyst Confirmed
Dyne Therapeutics (NASDAQ:DYN) shares fell 31.0% to $16.76 in premarket trading, compared with a previous close of $24.28. No official company announcement confirming a reason for the share-price movement had been identified at the time of writing, and the cause of the decline remains unclear.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
AIC Project and VELO Protocol: Technical Analysis, Market Status, and Derivatives Opportunities
-
2
POG Token: Project Overview, Market Status, and Trading Channel Analysis
-
3
WELUPS Coin: Investment Considerations Amidst Low Liquidity and Zero Circulating Supply
-
4
Ethereum 2.0 Terminology Deprecated: A Look Back at Major Ethereum Upgrades and Future Roadmap
-
5
KKC Coin: A Multifaceted Analysis – The Current State of Homonymous Tokens Like Kabberry Coin and Knoknok
-
6
Houthi attacks on multiple Saudi energy facilities disrupt operations, Brent crude rises 1.65% intraday, nearing $100 mark.
-
7
Binance Founder Changpeng Zhao (CZ): Still hiring humans.
-
8
Saudi Arabia announced that attacks have caused several energy facilities in its southern region to cease operations.
-
9
Brent crude oil climbs toward $100 as the Strait of Hormuz remains constrained
-
10
China's integrated circuit exports surged by 129.83% year-on-year in August, while crude oil imports increased by 6.2% month-on-month.
Markets Today
Recommended Reading







